Efficacy of Dapagliflozin in Patients with Type 2 Diabetes Mellitus and Baseline HbA1c=9.0%

被引：0
|
作者：
Katz, Arie
Yeh, Helen
Sugg, Jennifer E.
Parikh, Shamik J.
List, James F.
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1094-P
引用
收藏
页码：A284 / A285
页数：2
相关论文
共 50 条
  • [21] Effect of orlistat in patients with type 2 diabetes at differing baseline HbA1c levels
    De Fronzo, R
    Pi-Sunyer, FX
    DIABETES, 2002, 51 : A412 - A412
  • [22] Efficacy of Alternative Medicine in Reducing Hemoglobin A1c (HbA1c) in Type 2 Diabetes Mellitus
    Kumar, Sagar
    Kumari, Priyanka
    Kumar, Vikash
    Fatima, Maham
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
  • [23] Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes with a High Baseline A1c
    Skolnik, Neil
    Bonnes, Harmony
    Katz, Arie
    Yeh, Helen
    DIABETES, 2015, 64 : A653 - A653
  • [24] DIABETES Low HbA1c levels and mortality in type 2 diabetes mellitus
    Ali, Shamsa
    Fonseca, Vivian A.
    NATURE REVIEWS ENDOCRINOLOGY, 2010, 6 (07) : 359 - 360
  • [25] Measurement of Quality of Life in Patients with Type 1 and Type 2 Diabetes mellitus based on HbA1c
    Nawras, Al-Taie
    Maftei, Delia
    Kautzky-Willer, Alexandra
    Krebs, Michael
    Stingl, Harald
    WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : S488 - S488
  • [26] Pioglitazone Amplifies the Decrease in HbA1c and Prevents the Increase in Plasma Ketone Caused by Dapagliflozin in Type 1 Diabetes Mellitus Patients
    Abdul-Ghani, Muhammad
    Baskoy, Gozde
    Nakhleh, Afif
    Abdelgani, Siham
    Al-Mulla, Fahd
    Abu-Farha, Mohamed
    Alajmi, Fahad
    Alessa, Thamer
    Defronzo, Ralph A.
    Shehadeh, Naim
    DIABETES, 2024, 73
  • [27] Adherence to the Mediterranean Diet in Patients with Type 2 Diabetes Mellitus and HbA1c Level
    Diez-Espino, Javier
    Buil-Cosiales, Pilar
    Serrano-Martinez, Manuel
    Toledo, Estefania
    Salas-Salvado, Jordi
    Angel Martinez-Gonzalez, Miguel
    ANNALS OF NUTRITION AND METABOLISM, 2011, 58 (01) : 74 - 78
  • [28] An alternative approach to modelling HbA1c trajectories in patients with type 2 diabetes mellitus
    McEwan, Phil
    Bennett, Hayley
    Qin, Lei
    Bergenheim, Klas
    Gordon, Jason
    Evans, Marc
    DIABETES OBESITY & METABOLISM, 2017, 19 (05): : 628 - 634
  • [29] Evaluation of HbA1c as a Screening for Type 2 Diabetes Mellitus in Korea
    Yang, Taeyoung
    Kim, Ji-Hun
    Yun, Mijung
    Choi, Kui Sung
    Park, Byung Soon
    Kim, Soul
    Ro, Eun Young
    DIABETES, 2015, 64 : A410 - A410
  • [30] Combined HbA1c and Systolic Blood Pressure Reduction With Dapagliflozin in Patients With Both Inadequately Controlled Type 2 Diabetes Mellitus and Hypertension
    Weber, Michael A.
    List, James
    Mansfield, Traci A.
    Parikh, Shamik J.
    Ptaszynska, Agata
    CIRCULATION, 2014, 130
12345